Arvee Laboratories India Ltd Stock Price Today (NSE: ARVEE)
Fundamental Score
Arvee Laboratories India Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Arvee Laboratories India Ltd share price today is ₹158.61, down 0.87% on NSE/BSE as of 19 June 2026. Arvee Laboratories India Ltd (ARVEE) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of ₹176.04 (Cr). The 52-week high for ARVEE share price is ₹290.78 and the 52-week low is ₹129.11. At a P/E ratio of 440.10x, ARVEE is currently trading above its industry average P/E of 29.20x. The company has a Return on Equity (ROE) of 7.12% and a debt-to-equity ratio of 0.03.
Arvee Laboratories India Ltd Share Price Chart — NSE/BSE Historical Performance
Arvee Laboratories India Ltd share price chart: -3.44% return over the past month. 52-week high ₹290.78, 52-week low ₹129.11.
Arvee Laboratories India Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹160.00 | ₹161.00 | ₹155.40 | ₹158.61 | 111.00 (Cr) | |
| ₹160.01 | ₹163.40 | ₹159.00 | ₹160.00 | 662.00 (Cr) | |
| ₹168.00 | ₹168.00 | ₹159.89 | ₹165.23 | 243.00 (Cr) | |
| ₹158.00 | ₹163.40 | ₹156.42 | ₹160.03 | 233.00 (Cr) | |
| ₹163.81 | ₹163.81 | ₹155.00 | ₹159.33 | 575.00 (Cr) | |
| ₹157.65 | ₹164.40 | ₹157.65 | ₹163.68 | 491.00 (Cr) | |
| ₹161.00 | ₹164.40 | ₹157.00 | ₹157.65 | 581.00 (Cr) | |
| ₹160.20 | ₹165.39 | ₹160.00 | ₹161.00 | 726.00 (Cr) | |
| ₹167.20 | ₹167.20 | ₹161.40 | ₹161.66 | 233.00 (Cr) | |
| ₹162.00 | ₹166.75 | ₹158.00 | ₹163.89 | 1.25K (Cr) |
Arvee Laboratories India Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹160.01 | ₹163.40 | ₹155.40 | ₹158.61 | -0.87% | |
| ₹168.00 | ₹176.00 | ₹147.15 | ₹165.23 | -1.65% | |
| ₹141.20 | ₹186.19 | ₹130.40 | ₹168.00 | +18.98% | |
| ₹150.00 | ₹160.00 | ₹129.11 | ₹133.86 | -10.76% | |
| ₹160.00 | ₹172.00 | ₹151.55 | ₹155.00 | -3.13% | |
| ₹213.33 | ₹221.50 | ₹146.50 | ₹156.88 | -26.46% | |
| ₹165.00 | ₹290.78 | ₹158.14 | ₹213.33 | +29.29% | |
| ₹164.00 | ₹175.75 | ₹155.00 | ₹160.54 | -2.11% | |
| ₹155.40 | ₹170.00 | ₹153.00 | ₹163.61 | +5.28% | |
| ₹167.00 | ₹185.90 | ₹152.20 | ₹154.85 | -7.28% | |
| ₹173.07 | ₹176.80 | ₹159.00 | ₹160.80 | -7.09% | |
| ₹185.00 | ₹214.50 | ₹159.20 | ₹173.07 | -6.45% |
AI Research Briefing
Powered by Gemini · 2026-04-09
Micro-cap specialty chemical play trading at a ludicrous valuation with negative free cash flow and a 'Strong Sell' rating.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Arvee Laboratories has experienced significant price volatility, with shares hitting both upper and lower circuits in March 2026. On April 8, 2026, the stock price increased by 10.00% to
CORE STORY (THE REAL GAME)
Arvee is a micro-cap specialty chemical company riding the India specialty chemical growth narrative, manufacturing polymer modifiers, contrast media intermediates and drug intermediates. The real game is whether they can scale production and maintain margins in a competitive landscape.
- India specialty chemical growth narrative
- Recent QoQ revenue growth of 169.45%
- Net profit growth of 1080.2% YoY in Q4
- Significant order wins
- Successful capacity expansion
- Improved profitability and cash flow
- Micro/SME cap implies high liquidity risk
- Sky-high valuation (P/E 440.1x vs Industry P/E 29.2x)
- Negative free cash flow of ₹-1.56 Cr over 5 years
No FII or DII holdings reported. Promoter holding steady at 73.5%.
India's specialty chemicals sector is poised for significant growth, driven by expanding end-use industries and rising domestic demand.
No - Free Cash Flow 5Y: ₹-1.56 Cr
Arvee needs to demonstrate consistent profitability and cash generation to justify its valuation. Failure to do so will lead to a sharp correction.
Primary Thesis Risk
Unsustainable valuation and poor cash flow could lead to a significant price correction.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Arvee Laboratories India Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Arvee Laboratories India Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ARVEE across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Conservative Debt Levels (D/E: 0.03)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (73.50%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (7.12%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Premium Valuation Risk (P/E: 440.10x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-98.98%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-72.47%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-3.26% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-0.13% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-0.09% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Negative Free Cash Flow (₹-1.56 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Arvee Laboratories India Ltd vs Specialty Chemicals Peers
Peer Comparison - Specialty Chemicals
Compare Arvee Laboratories India Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
15.9/100 | ₹158.61₹159 | ₹176.04₹176.04 | 440.10Average 440.1 Average | 7.12%Poor 7.12% Poor | 10.00%Average 10.00% Average | 0.03Excellent 0.0 Excellent | -0.09%Poor -0.09% Poor | -3.26%Poor -3.26% Poor | 0.00% | |
Pidilite Industries LimitedPidilite Indust... PIDILITIND • 500331 | 60.4/100 | ₹1480.70₹1481 | ₹149466.57₹149466.57 | 66.59Average 66.6 Average | 23.05%Excellent 23.05% Excellent | 29.84%Excellent 29.84% Excellent | 0.05Excellent 0.1 Excellent | 12.63%Good 12.63% Good | 12.49%Good 12.49% Good | 0.68% |
Gujarat Fluorochemicals LtdGujarat Fluoroc... FLUOROCHEM • 542812 | 51.5/100 | ₹3682.10₹3682 | ₹37241.99₹37241.99 | 54.77Average 54.8 Average | 8.29%Poor 8.29% Poor | 9.89%Poor 9.89% Poor | 0.23Excellent 0.2 Excellent | 21.05%Excellent 21.05% Excellent | 12.69%Good 12.69% Good | 0.09% |
Navin Fluorine International LtdNavin Fluorine ... NAVINFLUOR • 532504 | 40.6/100 | ₹7244.50₹7245 | ₹29462.02₹29462.02 | 66.34Average 66.3 Average | 11.52%Average 11.52% Average | 11.68%Average 11.68% Average | 0.33Excellent 0.3 Excellent | -6.59%Poor -6.59% Poor | 17.22%Excellent 17.22% Excellent | 0.21% |
Deepak Nitrite LtdDeepak Nitrite ... DEEPAKNTR • 506401 | 40.2/100 | ₹1714.80₹1715 | ₹21083.64₹21083.64 | 39.67Average 39.7 Average | 13.36%Average 13.36% Average | 16.28%Good 16.28% Good | 0.23Excellent 0.2 Excellent | 2.02%Average 2.02% Average | 14.38%Good 14.38% Good | 0.49% |
BASF India LtdBASF India Ltd... BASF • 500042 | 52/100 | ₹3430.20₹3430 | ₹17807.40₹17807.40 | 46.29Average 46.3 Average | 13.73%Average 13.73% Average | 18.02%Good 18.02% Good | 0.04Excellent 0.0 Excellent | 57.98%Excellent 57.98% Excellent | 14.83%Good 14.83% Good | 0.49% |
Atul LtdAtul Ltd... ATUL • 500027 | 50.5/100 | ₹7002.50₹7003 | ₹17066.13₹17066.13 | 31.47Average 31.5 Average | 9.10%Poor 9.10% Poor | 12.81%Average 12.81% Average | 0.03Excellent 0.0 Excellent | -5.82%Poor -5.82% Poor | 6.41%Good 6.41% Good | 0.43% |
Vinati Organics LtdVinati Organics... VINATIORGA • 524200 | 57.2/100 | ₹1325.10₹1325 | ₹16256.72₹16256.72 | 34.97Average 35.0 Average | 15.75%Good 15.75% Good | 20.61%Excellent 20.61% Excellent | 0.00Excellent 0.0 Excellent | 4.46%Average 4.46% Average | 16.92%Excellent 16.92% Excellent | 0.48% |
Anupam Rasayan India LtdAnupam Rasayan ... ANURAS • 543275 | 37.5/100 | ₹1368.00₹1368 | ₹14036.52₹14036.52 | 92.84Average 92.8 Average | 3.32%Poor 3.32% Poor | 7.33%Poor 7.33% Poor | 0.38Excellent 0.4 Excellent | 11.97%Good 11.97% Good | 22.13%Excellent 22.13% Excellent | 0.06% |
Aarti Industries LtdAarti Industrie... AARTIIND • 524208 | 41.9/100 | ₹500.75₹501 | ₹13796.68₹13796.68 | 51.29Average 51.3 Average | 6.03%Poor 6.03% Poor | 6.32%Poor 6.32% Poor | 0.70Good 0.7 Good | -9.09%Poor -9.09% Poor | 11.68%Good 11.68% Good | 0.26% |
Fine Organic Industries LtdFine Organic In... FINEORG • 541557 | 60.5/100 | ₹4677.30₹4677 | ₹13359.76₹13359.76 | 33.38Average 33.4 Average | 19.47%Good 19.47% Good | 26.39%Excellent 26.39% Excellent | 0.01Excellent 0.0 Excellent | 20.04%Excellent 20.04% Excellent | 16.93%Excellent 16.93% Excellent | 0.25% |
Top Specialty Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Pidilite Industries Limited share price149466.57 Cr
- Gujarat Fluorochemicals Ltd share price37241.99 Cr
- Navin Fluorine International Ltd share price29462.02 Cr
- Deepak Nitrite Ltd share price21083.64 Cr
- BASF India Ltd share price17807.40 Cr
Arvee Laboratories India Ltd PE Ratio History
Historical price-to-earnings ratio for ARVEE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.95 | ₹173.77 | 182.9x |
| FY 2023 | ₹3.74 | ₹172.95 | 46.2x |
| FY 2022 | ₹2.34 | ₹129.65 | 55.4x |
| FY 2021 | ₹3.24 | ₹87.25 | 26.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Arvee Laboratories India Ltd Quarterly Performance
Latest quarterly metrics for ARVEE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-72.47%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-98.98%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-3.26%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-0.09%
Compounded annual net profit growth over 5 years
Arvee Laboratories India Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ARVEE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Arvee Laboratories India Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Arvee Laboratories India Ltd (ARVEE) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Arvee Laboratories India Ltd
About ARVEE (Arvee Laboratories India Ltd)
Arvee Laboratories India Ltd is a pioneering force in the realm of specialty chemicals, crafting innovative solutions that cater to a diverse range of industrial applications. At t...he heart of their operations lies a commitment to precision and quality, manufacturing complex molecules with exacting standards. Their portfolio showcases a deep understanding of chemical synthesis, producing specialized intermediates and fine chemicals that serve as crucial building blocks for various downstream industries. Through meticulous research and development, Arvee Laboratories is constantly pushing the boundaries of chemical innovation, forging new pathways to enhance product performance and efficiency across various sectors. Their dedication to customer satisfaction and technical expertise makes them a trusted partner for businesses seeking tailored chemical solutions. The company's focus centers on delivering high-performance chemicals that address specific industry needs, particularly in the areas of polymers and imaging. Their specialized offerings play a critical role in modifying and enhancing the properties of polymers, contributing to improved durability, flexibility, and overall performance in diverse applications. They also cater to the medical imaging sector, providing key intermediates used in the production of contrast media agents. These compounds enable clearer and more detailed medical imaging, thereby aiding in accurate diagnoses. Arvee Laboratories' dedication to both polymer modification and medical imaging underscores their commitment to supporting advancements in materials science and healthcare. Arvee Laboratories India Ltd prides itself on its state-of-the-art manufacturing facilities and a highly skilled workforce dedicated to upholding the highest quality standards. Their manufacturing processes adhere to strict environmental and safety regulations, ensuring responsible and sustainable chemical production. By leveraging advanced technology and continuous improvement initiatives, Arvee Laboratories strives to optimize its operations and minimize its environmental footprint. The company's unwavering commitment to excellence, combined with its strong focus on customer collaboration, positions it as a reliable and innovative provider of specialty chemicals in the Indian market and beyond.
Company Details
Key Leadership
ARVEE Share Price: Frequently Asked Questions
What is the current share price of Arvee Laboratories India Ltd?
Arvee Laboratories India Ltd (ARVEE) trades at ₹158.61 on NSE. Market cap ₹176.04 (Cr). Educational data only.
What is the P/E ratio of Arvee Laboratories India Ltd?
Arvee Laboratories India Ltd has a P/E of 440.10x vs industry average 29.20x.
What is the Bull Run score for Arvee Laboratories India Ltd?
Arvee Laboratories India Ltd has a Bull Run score of 15.9/100 based on 25+ financial parameters.
Does Arvee Laboratories India Ltd pay dividends?
Arvee Laboratories India Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Arvee Laboratories India Ltd?
Arvee Laboratories India Ltd has ROE of 7.12%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Arvee Laboratories India Ltd?
Arvee Laboratories India Ltd has debt-to-equity of 0.03.
Is Arvee Laboratories India Ltd a good investment?
Bull Run gives Arvee Laboratories India Ltd a score of 15.9/100. This is not investment advice — consult a SEBI-registered advisor.